DUBLIN–(BUSINESS WIRE)–The “2019 Peptide Drug Design & Delivery Conference” conference has been added to ResearchAndMarkets.com’s offering.
The 2019 Peptide Drug Design & Delivery Summit will bring together key decision makers and innovators within this rapidly growing field. This intensive 3-Day program will examine various peptide discovery and synthesis techniques and synthesized and modified peptides. Hear from over 50 peptide drug commercialization experts on a variety of sessions including peptide engineering, peptidomimetics, peptide conjugation, and cell-penetrating peptides for molecular imaging.
Additionally, 2019’s Summit will examine novel strategies for improving peptide stability and half-life, along with novel routes of administration. Case studies will be presented that illustrate the progress made in developing efficacious peptide therapeutics, while leaders in the field point the way to the future for these promising drugs. Meet and network with 160+ drug development professionals and walk away wit over 2 years of new peptide commercialization strategies in just 3 days!
You will learn:
- Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
- 3D printing for biopharmaceuticals: Next-generation industrial scale-up
- Advances in peptide-based drug discovery
- Designing optimal peptides; Peptidomimetics
- Rational and structure-based design of novel peptides
- Peptide conjugation techniques
- Targeted & localized delivery
- Modeling & simulation approaches
- Cell penetrating peptides in molecular imaging and drug delivery
- Antimicrobial peptides in immunotherapy
- Peptide synthesis; Biosynthesis and modified peptides
- Discovery and development of protease inhibitors
- Breakthrough protein targets
- Peptide catalysts and enzyme mimicry
- Engineering antibodies
- Parenteral routes of administration
- Pediatric dosage forms & delivery
Benefits:
- 50+ industry-led speaker faculty over 2 full days sharing innovative drug development take-home strategies
- 14+ hours of networking sessions and breaks over two full days to learn from network with pharmaceutical and biotech senior peptide, formulation, development and delivery professionals
- 160+ Senior peptide participants spanning pharma, biotech and specialty delivery & technology companies
- Dynamic Exhibition Hall with multiple leading synthesis, conjugation, formulation development, delivery and modeling experts
- Multiple innovative go-to-market & take-home strategies and learn 2 years of drug delivery strategies and approaches in just 3 days!
- Network with healthcare’s revolutionaries and join our growing community of peptide drug product development professionals
- 2 Events for the Price of One! Co-located and shared exhibition with the 2019 Controlled & Modified Drug Release Summit
Agenda
Pre-Conference Workshop Day – Tuesday, August 27th, 2019
9:55am – 10:00am
Registration Opens for Workshop Day Participants
10:00am – 1:00pm
WORKSHOP A: Recent Advances in 3D Printing of Large & Small Molecule Drug Products
3:00pm – 5:30pm
WORKSHOP B: Oral Controlled Release Solid Dosage Forms
Main Summit Day One – Wednesday, August 28th, 2019
7:30am – 8:55am
Registration Opens & Continental Breakfast for Summit Participants
8:55am – 9:05am
Collaboration is King! Ice Breaker
9:05am – 9:10am
Welcome and Chairperson’s Introduction & Opening Remarks
9:10am – 9:50am
KEYNOTE: Precision Medicine & Healthcare Delivery: Making Precision Medicine a Reality via Novel Technology Advancements
9:50am – 10:30am
KEYNOTE: Innovating Bioactive Materials: The Cross Section of Drug Delivery and Nano-Surface Therapeutics
10:30am – 11:00am
Breakthrough Innovations in the Next Generation of Inhalation Drug Delivery: Alternative Therapeutic Fields for Drug Development
11:00am – 11:30am
Morning Networking & Refreshment Break in Exhibit Hall
11:30am – 12:10pm
Development of Accelerated Methods to Predict Long-Term Peptide Release and Polymer Degradation of a 4-6 Month Extended Release Formulation
12:10pm – 12:50pm
PANEL SESSION: Accelerating Time to Market Through Innovation in Formulation Design and Drug Delivery
12:50pm – 2:00pm
Networking Lunch in the Exhibit Hall
2:00pm – 2:35pm
Combining In-Vivo Animal Models with Physiologically Based Pharmacokinetics (PBPK) Modeling to Optimize Oral Controlled Release Dosage Forms
2:35pm – 3:10pm
Nanoparticle Formulation Modalities: Light-Scattering Tools for Screening and Characterization
3:10pm – 3:40pm
Afternoon Networking & Refreshment Break in Exhibit Hall
3:40pm – 4:15pm
Improving Adherence with Pediatric Dosage Forms – Oral Controlled Modified Release Formulations via Minitablet Development
4:15pm – 4:50pm
DEP Drug Delivery: Developing Enhanced Therapies
4:50pm – 5:30pm
Nucleic Acid Delivery for Enabling MRNA: Enabling the next Generation of Therapeutics
5:35pm
Chair’s Closing Remarks, Drinks Reception and End of Day One
Main Summit Day Two – Thursday, August 29th, 2019
8:00am – 8:55am
Continental Breakfast for Conference Participants
8:55am – 9:00am
Chairperson’s Introduction & Opening Remarks
9:00am – 9:35am
Utilizing Biopharmaceutical Modeling for Particle size Specification of Oral Extended Release Products
9:35am – 10:10am
Delivery and Controlled Release from Nanoparticles for Drug Delivery & Imaging
10:10am – 10:40am
Morning Networking & Refreshment Break in Exhibit Hall
10:40am – 11:15am
Newly Developed Controlled Release Subcutaneous Formulations for Long Acting Implants for HIV
11:15am – 11:50am
Expediting Product Development for Precision Medicine
11:50am – 12:25pm
Recent Advances in the Commercialization of Sustained Release Ocular Drug Delivery Systems
Matrix-Binding Peptides for Targeted Delivery to Tissues
12:25pm – 1:30pm
Networking Lunch in the Exhibit Hall
1:30pm – 2:05pm
In Situ Forming Injectable Hydrogel Formulations for Controlled Delivery of Peptides and Proteins
2:05pm – 2:40pm
How do you Build In Vivo – In Vitro Correlation to Develop your Release Performance?
2:40pm – 3:00pm
Afternoon Networking & Refreshment Break in Exhibit Hall
3:00pm – 3:35pm
Using Solid-State Characterization to Study Amorphous Drug-Excipient Interactions
3:35pm – 4:10pm
Utilizing Novel Modified Release Technologies for the Future of Patient-Centered Drug Delivery
4:10pm – 4:45pm
New Modified-Release Technology & Role of Physico-Chemical Properties of Polymers in Hot Melt Extrusion
4:45pm
Chair’s Wrap-up & Conference Concludes
For more information about this conference visit https://www.researchandmarkets.com/r/gng1xy
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery